Content Type: Article

  • OSHA Issues COVID-19 Vaccination and Testing Emergency Temporary Standard

    OSHA Issues COVID-19 Vaccination and Testing Emergency Temporary Standard

    ARTICLE / CLIENT ALERT

    OSHA Issues COVID-19 Vaccination and Testing Emergency Temporary Standard

    November 10, 2021

    Read time: 20 min

    Key takeaways
    Overview

    On Nov. 4, 2021, the Occupational Safety and Health Administration (“OSHA”) issued the COVID-19 Vaccination and Testing Emergency Temporary Standard (“ETS”). OSHA relied on its determination that COVID-19 presents a “grave danger” to unvaccinated employees in the workplace, and that an ETS is “necessary” to protect workers from the risk of contracting COVID-19 at work as the legal basis for issuing the ETS. The ETS establishes mandatory requirements for private employers with 100 or more employees to minimize the spread of COVID-19 in the workplace.

    Employers Covered by the ETS

    The ETS applies to employers that have a total of 100 or more employees. Full-time and part-time employees, remote employees, employees who work outdoors and temporary and seasonal workers hired directly by the employer[1] all count toward the 100-employee threshold.[2] In determining if an employer meets this threshold, the employer must aggregate the total number of employees in all of its U.S. workplaces and locations.

    Employers who have 100 or more employees on Nov. 5, 2021 are bound by the ETS for the duration of the time the ETS is in effect (even if their employee-count shrinks below 100).[3] An employer that initially has less than 100 employees will be bound by the ETS once it employs 100 or more employees. Federal contractors covered under the Safer Federal Workforce Task Force COVID-19 Workplace Safety: Guidance for Federal Contractors and Subcontractors Executive Order, and healthcare employees in settings covered by OSHA’s previously issued, June 2021 COVID-19 Healthcare ETS[4] are not subject to the ETS.[5]

    While an employer with 100 or more employees must comply with the ETS, not all of its employees may be subject to its requirements. The ETS generally only applies to employees who report to a workplace where other individuals are present, such as coworkers or customers. The ETS applies to employees who work at certain offsite locations, including in company vehicles, but does not apply to employees who work exclusively at home or outdoors. For example, if an employer has 100 employees who work exclusively at home and 50 employees who work in the office, the employer would be bound by the ETS because it has more than 100 employees, but the ETS requirements would only apply to those 50 employees who work in the office.

    Compliance With the ETS

    Pursuant to the ETS, covered employers must develop, implement and enforce a written mandatory COVID-19 vaccination policy or a policy that permits employees to choose either full vaccination or proof of weekly COVID-19 testing. Those employees choosing the testing option must also wear a face covering while in the workplace. Mandatory vaccination policies must require all employees to be fully vaccinated,[6] with exceptions for those employees who are legally entitled to a reasonable accommodation to the vaccination requirement due to a medical disability or a sincerely held religious belief, practice or observance.[7] Employers are not required to submit their written policies to OSHA, unless OSHA requests them to do so. The ETS does not displace collective bargaining agreements with unions that have requirements that meet or exceed the ETS’ requirements.

    Compliance with the ETS requires covered employers to:

    • Determine the vaccination status of each employee, obtain acceptable proof of vaccination[8] and maintain records and a roster of each employee’s vaccination status (fully vaccinated, partially vaccinated, not fully vaccinated because of a religious or medical accommodation or not fully vaccinated because they have not provided acceptable proof of vaccination status). OSHA considers these vaccination records to be employee medical records and requires such personally identifiable medical information to be maintained in a confidential manner, including by storing such information separately from employees’ personnel files and limiting access to such information.
    • Support vaccination by providing employees reasonable time, including up to four hours of paid time off, to receive each vaccination dose and “reasonable time” and paid sick leave to recover from any side effects experienced following each dose.
    • Require employees to provide prompt notice to the employer when an employee receives a positive COVID-19 test or is diagnosed with COVID-19. Such employees must be removed from the workplace, regardless of vaccination status, and must not be allowed to return to work until the employee meets certain return-to-work criteria.
    • Ensure that employees who are not fully vaccinated are tested for COVID-19 at least weekly (if in the workplace at least once a week) or within seven days before returning to work (if away from the workplace for a week or longer). Employers are required to maintain a record of each employee’s required test results while the ETS is in effect.[9] These records must be treated as employee medical records and remain confidential.
    • Require each employee who is not fully vaccinated to wear an ETS-compliant face covering[10] when indoors or when occupying a vehicle with another person for work purposes, except in certain limited circumstances. Examples of such circumstances include when an employee is alone in a room with floor to ceiling walls and a closed door, for a limited time while an employee is eating or drinking, for security identification purposes or where the employer can show that the use of face coverings is not feasible or creates a greater hazard that would excuse compliance.
    • Report work-related COVID-19 fatalities and in-patient hospitalizations to OSHA.
    • Make available an employee’s COVID-19 vaccine documentation and any COVID-19 test results to that employee and to anyone with written authorized consent of the employee in question.
    • Employers must also make available to an employee the aggregate number of fully vaccinated employees at a workplace along with the total number of employees at that workplace.[11]
    • Provide each employee with information, in a language and at a literacy level the employee understands, about the workplace policies and procedures the employer establishes to implement this ETS, as well as the CDC document “Key Things to Know About COVID-19 Vaccines.” Employers must also provide additional information to unvaccinated employees, including information about the employer’s policies and procedures for COVID-19 testing and face coverings.

    Employers that previously implemented mandatory vaccination policies must evaluate and modify their policies to ensure they meet or exceed the requirements of this ETS.

    Effective Dates

    The ETS was effective immediately upon its publication in the Federal Register on Nov. 5, 2021. Employers must comply with all of the ETS’ requirements by Dec. 6, 2021, except that employers that offer COVID-19 testing as an option must begin testing unvaccinated employees by Jan. 4, 2022. Legal challenges to the ETS already have been filed in response to OSHA’s publication of the ETS, including challenges by twenty-five states in federal court to block the ETS. On Nov. 6, 2021, a federal court of appeals temporarily halted the enforcement of ETS due to apparent “grave statutory and constitutional issues” raised by the ETS. Action by the Supreme Court of the United States to either overrule or affirm the lower court’s order halting the enforcement of the ETS is likely forthcoming. Employers should be prepared to comply with the ETS by its original deadlines in the event the injunction against the ETS is removed.

    When employers change their policies or procedures related to implementing the ETS, they must provide such updated or additional information to all employees.

    Costs

    The ETS does not require employers to pay for the COVID-19 testing of its employees or to pay for face coverings. Employer payment for testing, however, may be required by other laws, regulations or collective bargaining agreements or other agreements.

    State Plans

    Employers in certain states and territories that contain their own OSHA-approved State Plans are not required to follow this ETS. Under the terms of such state plans, however, each state plan must contain standards that are “at least as effective” as the corresponding federal OSHA standard. States with such state plans must update their state plans to add a standard that is “at least as effective” as the ETS by Dec. 5, 2021. Although Connecticut, New Jersey and New York have state OSHA plans, their state plans are limited to public employers. Accordingly, private employers in the Tri-State area are bound by the federal OSHA ETS.

    Enforcement

    Employers who violate the ETS are subject to fines. OSHA fines for a single violation range from $1,000 to $13,653 dependent on the severity of the violation; willful or repeated violations result in penalties of up to $136,532. Similarly, OSHA is authorized to impose a penalty of up to $13,653 for each day that an employer fails to resolve an OSHA violation past a date specified in an OSHA notice to the employer. Employers should be aware that a bill is pending in Congress that would raise the maximum fines for single violations and failures to abate from $13,653 to $70,000, and fines for willful or repeated violations from $136,532 to $700,000.

    Next Steps

    Employers need to take action now to comply with the ETS, including by:

    1. Determining whether they meet the 100-employee threshold for coverage;
    2. Developing a written COVID-19 policy in compliance with the ETS;
    3. Developing a procedure to handle requests for medical and religious exemptions;
    4. Preparing the necessary notices and documents to employees as required by the ETS;
    5. Training supervisors on compliance with the ETS; and
    6. Communicating with employees regarding these requirements

    Authored by Mark E. Brossman, Ronald E. Richman, Max Garfield, Scott A. Gold and Abdulrahman Alwattar.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Employers do not need to include a staffing agency’s employees placed in the employer’s workplace.

    [2] Independent contractors do not count as employees.

    [3] OSHA anticipates that the ETS will be in effect for six months.

    [4] OSHA’s Healthcare ETS covers most health care workplaces, but does not cover employees in non-healthcare settings. These employees in non-healthcare settings are subject to this new ETS, even if their employer is a healthcare employer.

    [5] The U.S. Center for Medicare & Medicaid Services also released a regulation that requires healthcare organizations covered by Medicare and Medicaid to have their healthcare workers vaccinated.

    [6] Employees are “fully vaccinated” two weeks after their second dose in a two-dose series, such as the Pfizer or Moderna vaccines, or two weeks after a single-dose vaccine, such as Johnson & Johnson’s vaccine. At this time, booster shots and additional doses are not included in the ETS’ definition of fully vaccinated.

    [7] In October 2021, the EEOC updated its guidance on reasonable accommodations to employers’ mandatory vaccination policies, and published its internal Religious Accommodation Request Form as an example for employers to model their own religious accommodation request forms.

    [8] Pursuant to the ETS, an acceptable proof of vaccination status is: “(i) the record of immunization from a health care provider or pharmacy; (ii) a copy of the COVID-19 Vaccination Record Card; (iii) a copy of medical records documenting the vaccination; (iv) a copy of immunization records from a public health, state, or tribal immunization information system; or a copy of any other official documentation that contains the type of vaccine administered, date(s) of administration, and the name of the health care professional(s) or clinic site(s) administering the vaccine(s). A signed and dated employee attestation is acceptable in instances when an employee is unable to produce proof of vaccination.”

    [9] Following an employee’s positive COVID-19 test result or diagnosis, the testing requirements for this employee are temporarily suspended for 90 days.

    [10] OSHA broadly defines “face covering” to include both cloth and non-cloth masks, including homemade masks, provided such masks fit snugly and cover the individual’s nose and mouth.

    [11] Upon request for this information, employers must make these records available by the end of the next business day. Employees are entitled to only one free copy of each requested record: after receiving an initial, free copy of the record, an employee may be charged a reasonable fee for copying duplicative records.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Max Garfield

    Partner

    New York – 919 Third Avenue

    Abdulrahman Alwattar

    Associate

    New York – 919 Third Avenue

    More insights

  • CMS Finalizes Changes to Clarify Physician and NPP “Split (or Shared)” Billing Policy

    CMS Finalizes Changes to Clarify Physician and NPP “Split (or Shared)” Billing Policy

    ARTICLE / CLIENT ALERT

    CMS Finalizes Changes to Clarify Physician and NPP “Split (or Shared)” Billing Policy

    November 10, 2021

    Read time: 11 min

    Key takeaways
    Overview

    On November 2, 2021, the Centers for Medicare & Medicaid Services (CMS) issued the calendar year (CY) 2022 Medicare Physician Fee Schedule (MPFS) final rule which, among other policy and regulatory changes, finalized regulations codifying CMS requirements for billing for “split (or shared)” evaluation and management (E/M) visits under the MPFS. Split (or shared) visits are E/M visits provided in part by both physician and non-physician practitioners (NPPs) and are now defined at 42 CFR § 415.140. NPPs generally include nurse practitioners, physician assistants and clinical nurse specialists, and are also known outside of the Medicare program by other names, such as advanced practice practitioners. The finalized regulations generally reflect prior CMS guidance for billing “split/shared” visits, but also incorporates changes from the historical guidance that introduce new opportunities and restrictions on providing what are now known as split (or shared) visits.

    In depth

    BACKGROUND

    Medicare reimburses services paid under the MPFS and furnished by NPPs at 85% of the rate paid when a physician furnishes the same service. Under CMS regulations, when a patient visit is performed in part by a physician and in part by a NPP in a physician office setting, the physician is permitted to bill for the visit under their own NPI and receive the higher Medicare payment rate. These services are considered to be services furnished “incident to” a physician’s professional services and must meet other Medicare requirements for “incident to” services. CMS regulations have not historically addressed services furnished in part by a physician and in part by an NPP in the facility setting (e.g., hospitals and skilled nursing facilities (SNFs)). Instead, CMS relied solely on guidance found in the Medicare Claims Processing Manual (MCPM) to establish requirements for coverage and payment of such services. In May 2021, in response to a petition submitted under the US Department of Health and Human Services’ Good Guidance Practices Regulation, CMS withdrew the MCPM sections specifically addressing split (or shared) visits and indicated that CMS would reissue the guidance as proposed regulations.

    For dates of service on or after January 1, 2022, the new finalized regulations specify the requirements that must be met in order for a physician or NPP to bill a split (or shared) visit in a hospital, SNF or other facility setting. The final rule expands the clinical scenarios under which a healthcare professional can bill for services performed in part by another practitioner but also imposes restrictions on which performing practitioners can bill for the split (or shared) visit. While the finalized regulations provide the circumstances under which a physician or NPP may bill for professional services furnished to patients in a facility setting, this regulation addresses only services furnished in the facility setting and paid under MPFS. It does not appear to apply to facility services payable under a separate payment system (i.e., for hospitals, under the outpatient prospective payment system, or for SNFs, under the SNF prospective payment system).

    ANALYSIS

    In addition to clarifying when split (or shared) visits may be billed to Medicare, the finalized regulations modify CMS’s policy and permit physicians and NPPs to bill for split (or shared) visits for both new and established patients, critical care services and certain E/M visits in a SNF. In issuing the new rules, CMS indicated that prior guidance had been interpreted as limiting split (or shared) visit billing to established patients and prohibited billing for split (or shared) visits involving critical care services or in SNFs. The new regulations also define “split (or shared) visit” as E/M visits performed in part by a physician and NPP in institutional settings for which “incident to” payment is not available. This definition is intended to distinguish between the policy applicable to services furnished “incident to” the professional services of a physician in a physician office setting and the policy applicable to services furnished in a facility setting.

    In the final rule, CMS established which of the physician or NPP performing a split (or shared) visit can bill Medicare for the visit. This is an important concept because the visit is paid at a higher rate if the physician submits the claim rather than the NPP. Historically, in determining whether a physician or an NPP may bill for a split (or shared) visit, either the physician or the NPP could bill for the service as long as the billing practitioner performed a “substantive portion” of the visit. In the final rule, CMS codified its policy as proposed and, effective January 1, 2023, will utilize time as the key factor in determining whether the physician or the NPP performed the substantive portion of the visit. CMS finalized its proposal to limit the billing practitioner to the individual who performed more than 50% of the visit. In response to concerns raised from commenters, CMS provided a one-year transitional period that will permit either time or the provision of one of three key components of the visit (history, exam or medical decision-making) to be considered a “substantive portion” of the visit. If performing a key component of the visit is utilized, the practitioner who bills the visit must perform that component in its entirety. For critical care services, which are time-based codes, the physician or NPP must provide more than half of the total time in order to bill for the visit.

    CMS also finalized a list of activities that may count toward the total time of the E/M visit for purposes of determining the provider who performed the substantive portion of the visit. Under the final rule, documentation in the medical record must identify both professionals who performed the visit, and the individual who performed the substantive portion (and bills for the visit) must sign and date the medical record. CMS clarified that for all split (or shared) visits, while one of the practitioners must have face-to-face (in-person) contact with the patient, the face-to-face contact does not necessarily need to be with the practitioner who performs the substantive portion and bills for the visit.

    CMS also finalized the rule to provide important clarifications to its policy and to permit either a physician or an NPP to bill for split (or shared) visits for both new and established patients and for initial or subsequent visits. This expands the availability of split (or shared) visit billing in the facility setting.

    Under its previous policy, CMS did not permit healthcare professionals to bill for split (or shared) visits for critical care services or for E/M visits in a SNF. In the proposed rule, CMS proposed to permit healthcare professionals to bill for split (or shared visits) that are critical care services. CMS also proposed to expand split (or shared) visit billing to permit E/M visits to be furnished by a physician and a NPP in a SNF setting. CMS finalized both these proposals in the final rule. However, CMS also proposed to clarify that no other E/M visit can be billed for a patient on the same date as critical care services are furnished when the services are furnished by the same professional (or professionals) in the same specialty and group. In light of significant public comments, CMS did not adopt this limitation as proposed. Rather, the final rule provides that an E/M service can be billed for a patient on the same day as critical care services as long as the physician documents that (1) the E/M service was provided prior to the critical care service (when the patient did not require critical care), (2) the E/M service is medically necessary, (3) the E/M service is separate and distinct from the critical care services, and (4) the E/M service does not include any elements of the critical care services furnished later in the day. The critical care services must be reported using modifier -25 on the claim.

    Under previous guidance, a physician and an NPP had to be in the “same group” in order to bill for a split (or shared) visit. In the proposed rule, CMS declined to define “same group” for purposes of the new split (or shared) visit billing rule and sought comments on how to define same group. The final rule retains the requirement that split (or shared) visits must be performed by a physician and NPP who are in the same group, although, consistent with the proposed rule, CMS declined to adopt a definition for a “group.” Commenters agreed with CMS that appropriately defining a “group” in the context of split (or shared) visits is a complex issue. Although CMS considered several options, including using the definition under the Stark Law or considering practitioners under the same billing tax ID number to be the same group, CMS declined to adopt a definition of “group.” This determination is important because if the two practitioners are determined not to be in the same group, neither practitioner will be able to bill for the visit, assuming neither performed a complete E/M visit. As it currently stands, providers will need to determine how to ensure that physicians and NPPs are practicing in the “same group” to bill for split (or shared) visits without explicit guidance from CMS.

    CMS made it clear in the final rule that it will not pay for partial E/M visits. CMS also finalized its proposal to create a claim modifier that is mandatory for split (or shared) visits. This modifier will allow CMS to identify services furnished in part by NPPs and will allow for more targeted review of services furnished by physicians and NPPs. CMS did not provide the specific modifier that will be required.

    The following chart summarizes the previous guidance and the finalized revisions to CMS’s policy for split (or shared) visits in the final rule:

    Issue Prior Guidance Final Rule
    Who Can Bill? Practitioner who performs a “substantive portion” of the E/M visit Beginning January 1, 2022, the practitioner who performs more than half of the total (non-duplicated) time spent on the E/M visit or performs one of the three key components in its entirety (history, exam or medical decision-making); for critical care services, more than half of the total (non-duplicated) time spent on the E/M visit
    Beginning January 1, 2023, for all services, the practitioner who performs more than half of the total (non-duplicated) time spent on the E/M visit
    Setting of Care Institutional setting other than an SNF Any institutional setting, including SNFs (other than visits required to be performed in their entirety by a physician)
    Definition of “Same Group” Not defined Not defined at this time
    Medical Record Documentation Not specified Must identify the practitioners who performed the visit, and billing practitioner must sign and date the medical record
    Claim Modifier None Required for all split (or shared) visits; specific modifier not yet determined
    Critical Care Split (or shared) billing not permitted Split (or shared) billing permitted

    PRACTICAL IMPLICATIONS

    CMS finalized significant changes to its long-standing policy on billing for split (or shared) visits in the facility setting. The changes provide both new opportunities for billing such visits, including for new patients, services in SNFs and critical care visits, but also restrict the reimbursement opportunity for services that are performed primarily by NPPs. In light of the new regulations, providers utilizing the split (or shared) billing concept, or who may do so in the future, should review the changes and ensure that their split (or shared) billing policies are consistent with the new rules.

    Providers should begin considering how to track and document the time physicians and NPPs each spend furnishing services to patients. While this is consistent with the updated CPT guidance for E/M services, ensuring services meet the time requirements will also be important to the extent providers contemplate relying on the split (or shared) visit regulations to bill for services that are performed jointly by physicians and NPPs. While CMS has provided a one-year transition period for full implementation of the component of the rules governing how to evaluate whether a split (or shared) visit should be billed under the NPI of the physician or the NPI of the NPP who shared in furnishing services as part of the visit, this flexibility will end effective January 1, 2023. In addition, the medical record documentation and claim modifier requirements may necessitate modifications to longstanding documentation and billing practices for physicians and NPPs who furnish services in facility settings. Providers also should consider establishing and memorializing the definition of “same group” that will be used to determine which physicians and NPPs can jointly furnish services billed under the split (or shared) billing rules.

    Authors

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Caroline Reignley

    Partner

    Washington, DC

    More insights

  • Amendment Expands New York Whistleblower Protection Law

    Amendment Expands New York Whistleblower Protection Law

    ARTICLE / CLIENT ALERT

    Amendment Expands New York Whistleblower Protection Law

    November 8, 2021

    Read time: 4 min

    Key takeaways
    Overview

    On Oct. 28, 2021, Governor Hochul signed into law an amendment to the New York Whistleblower Protection Law (“Whistleblower Law”). The amended Whistleblower Law generally prohibits employers from retaliating against employees who disclose, or threaten to disclose, their employers’ violation of any law to supervisors, law enforcement or other government entities. The amendment, effective Jan. 26, 2022, greatly increases protections for employees and expands the risk of liability for employers.

    Increased Protection for Employees

    Prior to the amendment, the law only protected employees who reported actual violations of the law that presented a substantial and specific danger to public health or safety. The new amendment protects employees, former employees, and individual independent contractors (collectively, “Employees”), if they reasonably believe that their employer has a policy or practice that violates the law or poses a substantial and specific danger to public health or safety. The amended law prohibits employers from retaliating against Employees for reporting these potential violations.

    Under the current law, employees were required to first report to their supervisor and allow employers a reasonable opportunity to correct the violation. The new amendment has relaxed this requirement, requiring Employees to make a “good faith effort” to notify employers before reporting a violation. Employees do not need to notify employers if:

    • The Employee reasonably believes that (i) evidence might be destroyed or concealed if the Employee reports the violation to the supervisor, (ii) the Employee or another person might be physically harmed if the Employee reports to the supervisor, or (iii) the supervisor is already aware of the violation and will not correct it;
    • There is an imminent and serious danger to the public health or safety; or
    • One could reasonably expect that the violation could endanger the welfare of a minor.

    An Expanded Definition for Retaliation

    The amendment also greatly expands actions by employers that could constitute retaliation under the law. Retaliation was previously defined as when an employer discharged, suspended or demoted the employee. Retaliation now includes:

    • Any adverse action an employer or its agent takes to discharge, threaten, penalize or discriminate against an Employee; and
    • Actions or threats to harm a former Employee’s current or future employment or to report an Employee’s immigration status.

    Litigation and Damages

    Employees who believe their employers retaliated against them can sue their employers in civil court. The amendment extends the timeframe Employees can sue their employer from one to two years after the alleged retaliation occurred, and adds that the parties shall be entitled to a jury trial.

    A court can order an employer to reinstate the Employee or pay the Employee front pay, lost wages, benefits, and the Employees’ attorneys’ fees. Under the amendment, employers may be ordered to pay a civil penalty of up to $10,000, and pay punitive damages if the employer willfully or maliciously violated the law.

    Mandatory Actions for Employers

    Employers are required to post a notice in their offices informing Employees of their rights under the amended Whistleblower Law. Employers must post the notice conspicuously in easily accessible and well lit locations that are frequently visited by Employees and job applicants. We expect the New York State Department of Labor will be issuing a poster.

    Please contact Mark E. Brossman, Ronald E. Richman, Max Garfield, Scott A. Gold, Donna K. Lazarus, Abdulrahman Alwattar or Andrew B. Lowy if you have any questions about these changes to the Whistleblower Law.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Max Garfield

    Partner

    New York – 919 Third Avenue

    Donna K. Lazarus

    Partner

    New York – 919 Third Avenue

    Abdulrahman Alwattar

    Associate

    New York – 919 Third Avenue

    Andrew B. Lowy

    Partner

    New York – 919 Third Avenue

    More insights

  • President’s Working Group Issues Interagency Risk Assessment of Stablecoins

    President’s Working Group Issues Interagency Risk Assessment of Stablecoins

    ARTICLE / CLIENT ALERT

    President’s Working Group Issues Interagency Risk Assessment of Stablecoins

    November 8, 2021

    Read time: 8 min

    Key takeaways
    Overview

    On Nov. 1, 2021, The President’s Working Group on Financial Markets, the Federal Deposit Insurance Corporation (FDIC) and the Office of the Comptroller of the Currency (OCC) (collectively, the “Agencies”) released an interagency report (“Report”)[1] concerning “payment stablecoins,” which the Report defined as “stablecoins that are designed to maintain a stable value relative to a fiat currency and, therefore, have the potential to be used as a widespread means of payment.”[2]

    The Report focused on the risks stablecoins pose to the safety and efficiency of the financial market, along with recommended actions that Congress, as well as the Agencies, could take to address those risks.[3] The Report appears motivated, in part, by the rapid growth of stablecoins in the financial system, noting a market capitalization increase of nearly 500% over the preceding twelve months.[4]

    Stablecoin Risks and Regulatory Gaps

    The Report identified three primary “prudential concerns” stablecoins pose to financial markets[5]:

    • Loss of Value: Risk to Stablecoin Users and Stablecoin Runs

      The Agencies found that confidence in a stablecoin may be undermined by several factors, such as: (1) reserve assets could depreciate or become illiquid; (2) failure to adequately safeguard reserve assets; (3) lack of clarity regarding redemption rights of stablecoin holders; and (4) operational risks relating to cybersecurity and data security.[6] In the event a stablecoin did not perform according to expectations, the Report notes the threat of systemic risk and a “run” on the stablecoin, which may have the potential to “amplify a shock to the economy and the financial system.”[7]

    • Payment System Risks

      The Report indicates that payment stablecoins present many of the same risks that traditional payment systems face, including credit risk, liquidity risk, operational risk, settlement risk and risks from ineffective system governance.[8] These risks could cause payment systems to be less available or reliable to users, or create channels in which financial shocks or disruptions spread.[9]

    • Risks of Scale: Systemic Risk and Concentration of Economic Power

      The Agencies note that the potential for an individual stablecoin to scale rapidly raises different policy issues. First, the failure of a key participant in a stablecoin arrangement, such as a custodial wallet provider or a stablecoin issuer, could pose systemic risk.[10] Second, the combination or merger of a stablecoin issuer or a wallet provider with a commercial firm could lead to an inappropriate share of economic power.[11] Third, the wide adoption of a stablecoin could create anti-competition concerns. For example, it could be difficult for a user of a widely adopted stablecoin to switch to a different payment product or service.[12]

    The Report identified regulatory gaps in stablecoin arrangements that could exacerbate the risks identified above.

    • There is no consistent set of regulatory standards to address such prudential risks.[13] Certain entities, like digital wallet providers, may be subject to varied levels of state regulation and supervision depending on the services they offer and the specific states in which an arrangement or transaction occurs.[14]
    • The Report noted that, given the multiple parties in a single stablecoin arrangement, transparency into the nature of the services and transactions is required in order for proper supervisory oversight to exist.[15]

    Given these perceived regulatory gaps, the Agencies believe a comprehensive regulatory framework is needed to ensure consistent regulation, increase transparency into key aspects of stablecoin arrangements, and to ensure that stablecoins function properly under both normal and distressed market conditions.

    Recommended Congressional Actions

    To address these risks, the Report made the following three recommendations to Congress.

    Require Stablecoin Issuers Be Insured Depository Institutions

    The Report recommended that Congress pass legislation that would require stablecoin issuers to be insured depository institutions, which requires being subject to capital and liquidity standards that aim to ensure the safety of the financial system. Requiring stablecoin issuers to be insured depository institutions would help avoid risks to stablecoin users (e.g., customers not being able to liquidate the value of their deposits) and prevent “runs” on stablecoins that could cause negative systemic impacts.[16] The Report stated that stablecoin issuers should be subject to the appropriate regulations and supervision at both the depository institution and holding company levels.[17]

    Subject Digital Wallet Providers to Appropriate Federal Oversight

    The Report recommended that for further payment system risk mitigation, digital wallet providers should be subject to appropriate federal oversight.[18] Potential oversight would include restricting digital wallet providers from lending customer stablecoins, and ensuring digital wallet providers are compliant with risk-management, liquidity, and capital requirements.[19] In addition, the supervisor of a stablecoin issuer should have the authority to require any entity that performs critical functions of the stablecoin arrangement to comply with certain risk-management standards.[20]

    Require Affiliation and User Data Restrictions

    The Report recommended that stablecoin issuers be required to comply with activity restrictions that limit their ability to affiliate with commercial entities.[21] Moreover, the Report recommended that Congress consider similar requirements for digital wallet providers, including limiting affiliation with commercial entities or limiting use of user’s transaction data.[22] These recommendations are meant to address concerns about “systemic risks and concentration of economic power.”[23]

    The Report’s Interim Recommendations

    The Report noted that the U.S. Department of the Treasury is continuing to lead efforts at the Financial Action Task Force (FATF)[24] to ensure stablecoins are not facilitating money laundering and terrorism financing, and that such efforts are especially important due to the potential rapid increase in cross-border stablecoin payments that could amplify risks of money laundering and terrorism financing (as governments unevenly implement suggested FATF standards).[25] The Report also suggested that, in the absence of congressional action as recommended above, federal agencies should take interim measures to address the risks stablecoins pose.

    First, the Report recommended that existing federal agencies, including the Securities and Exchange Commission (SEC), the Commodity Futures Trading Commission (CFTC), and the Financial Crimes Enforcement Network (FinCEN), use their oversight power where appropriate, such as FinCEN mandating anti-money laundering obligations on stablecoin arrangements to the extent a stablecoin arrangement is offering “money transmission services.”[26] It should be noted that the report specifically referenced the SEC and CFTC as being able to exercise regulatory authority over stablecoins to the extent stablecoins function as securities, commodities, or derivatives.[27]

    Second, the Report recommended that, in the absence of congressional action, the Financial Stability Oversight Council (FSOC) designate certain activities conducted within stablecoin arrangements as, or as likely to become, systemically important payment, clearing, and settlement (PCS) activities.[28] Such designations would allow appropriate agencies to establish risk-management standards for institutions engaging in PCS activities.[29]

    The Report also specifically mentioned the CFPB using its authority to mitigate the financial risks associated with stablecoins.[30] In a statement responding to the report, CFPB Director Rohit Chopra asserted that, although the CFPB was not a member of the President’s Working Group that issued the report, the agency would still be “taking several steps related to this market.”[31]

    Conclusion

    The issuing of this collaborative report, in conjunction with the statement by CFPB Director Chopra, demonstrates that federal agencies are focused on the perceived risks and regulatory gaps associated with stablecoins. We will continue to monitor regulatory developments regarding the stablecoin ecosystem.

    Schulte Roth & Zabel lawyers are available to assist you in addressing any questions you may have regarding these developments. Please contact your attorney at Schulte Roth & Zabel or any of the following:

    Donald J. Mosher – New York (+1 212.756.2187)

    Kara A. Kuchar – New York (+1 212.756.2734)

    Jessica Sklute – New York (+1 212.756.2180)

    Melissa G.R. Goldstein – Washington, DC (+1 202.729.7471)

    Adam J. Barazani – New York (+1 212.756.2519)

    Jessica Romano – New York (+1 212.756.2205)

    Hadas A. Jacobi – New York (+1 212.756.2055)

    Steven T. Cummings – New York (+1 212.756.2251)


    [1] A copy of the Report is available here.

    [2] See Report at 2. For reference, stablecoins are digital assets whose value is tied to a national currency or other reference asset, and stablecoins are used often on digital asset trading platforms to facilitate trading, lending, and borrowing of other digital assets. Id. at 1.

    [3] See Id. at 2.

    [4] See Id. at 7 (“Stablecoin supply grew from $21.5 billion on October 19, 2020 to $127.9 billion as of October 18, 2021, representing an increase of approximately 495 percent.”).

    [5] See Id.

    [6] See Id. at 12.

    [7] See Id.

    [8] See Id. at 12, 13.

    [9] See Id. at 12.

    [10] See Id. at 14.

    [11] See Id.

    [12] See Id.

    [13] See Id.

    [14] See Id. at 13.

    [15] See Id. at 14, 15.

    [16] See Id. at 2. For example, if stablecoin issuers were required to be insured depository institutions, then they would be “subject to a special resolution regime that enables the orderly resolution of failed insured depository institutions by, among other mechanisms, protecting customers’ insured deposits, and according priority to deposit claims over those of general creditors[.]” See Id. at 16.

    [17] See Id. at 17.

    [18] See Id.

    [19] See Id.

    [20] See Id.

    [21] See Id.

    [22] See Id.

    [23] See Id.

    [24] Schulte Roth & Zabel LLP will soon publish a Client Alert discussing FATF’s “Updated Guidance for a Risk-Based Approach to Virtual Assets and Virtual Asset Service Providers.”

    [25] See Report at 19.

    [26] See Id. at 18.

    [27] See Id. at 11.

    [28] See Id. at 18.

    [29] See Id.

    [30] See Id.

    [31] A copy of CFPB Director Chopra’s statement can be found here.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Donald J. Mosher

    Partner

    New York – 919 Third Avenue

    Melissa G.R. Goldstein

    Partner

    New York – 919 Third Avenue

    Adam J. Barazani

    Partner

    New York – 919 Third Avenue

    More insights

  • CMS Issues COVID-19 Vaccination Interim Final Rule for Healthcare Facilities

    CMS Issues COVID-19 Vaccination Interim Final Rule for Healthcare Facilities

    ARTICLE / CLIENT ALERT

    CMS Issues COVID-19 Vaccination Interim Final Rule for Healthcare Facilities

    November 5, 2021

    Read time: 16 min

    Key takeaways
    Overview

    UPDATE:

    On November 16, 2021, 12 additional states—Montana, Alabama, Arizona, Georgia, Idaho, Indiana, Louisiana, Mississippi, Oklahoma, South Carolina, Utah and West Virginia—filed a complaint in the US District Court for the Western District of Louisiana (November 16 Complaint) requesting that the Interim Final Rule with comment period (IFR) that put in place the vaccination mandate applicable to certain covered health care facilities and staff (the CMS Mandate) be declared arbitrary and capricious, contrary to law and in excess of CMS’ statutory authority.

    The November 16 Complaint sets forth many of the same principles as the prior opposition in the US District Court for the Eastern District of Missouri, specifically, the November 16 Complaint requests for the CMS Mandate to be set aside because it:

    1. exceeds CMS’ statutory authority under the Administrative Procedure Act;
    2. violates Title 18 of the Social Security Act, by authorizing CMS to exercise “supervision and control” over healthcare institutions’ employment, administration, and operational practices.
    3. failed to proceed through notice and comment rulemaking;
    4. failed to be presented to Congress to provide an opportunity to pass a resolution disapproving the rule and to allow the Government Accountability Office to issue a report;
    5. represents an arbitrary and capricious agency action that fails to examine all relevant factors, including but not limited to how mandating vaccines may harm patients by exacerbating staff shortages and failing to consider alternative solutions;
    6. violates 42 U.S.C. § 1395z, which requires consultation with State agencies and other organizations in order to develop conditions of participation for providers of services;
    7. violates 42 U.S.C. § 1302 by failing to establish a rule that impacts a substantial number of small rural hospitals without first submitting the proposed rule for public comment and a regulatory impact analysis;
    8. places an unconstitutional condition on states’ receipt of federal funds by jeopardizing Medicare and Medicaid reimbursements;
    9. commandeers state officers to administer federal law; and
    10. usurps states’ rights in violation of the Tenth Amendment to the US Constitution

    Requested Relief

    The 12 states request a preliminary and permanent injunction and for the compliance period to be tolled until judicial review can be granted.

    Next Steps

    Unless and until an injunction is granted, the December 6, 2021, Phase I compliance date identified in the IFR is rapidly approaching. Health care providers and suppliers affected by the CMS Mandate should continue to prepare for implementation while watching for any actions in relation to this suit that may result in a delay of the anticipated compliance timeline.


    UPDATE:

    On November 10, 2021, ten states — Missouri, Nebraska, Arkansas, Kansas, Iowa, Wyoming, Alaska, South Dakota, North Dakota and New Hampshire (the Plaintiff States) filed a complaint in the US District Court for the Eastern District of Missouri requesting that the Interim Final Rule with comment period (IFR) that put in place the vaccination mandate applicable to certain covered health care facilities and staff (the CMS Mandate) be set aside as an “unlawful agency action under the Administrative Procedure Act” (APA), 5 USC §§ 701–706. This challenge comes on the heels of a similar action by attorneys general against the OSHA Emergency Temporary Standard, which mandates vaccination or testing for employees of companies with 100+ employees (OSHA ETS).

    Both the IFR and the OSHA ETS were released on November 5, 2021, as part of the Biden Administration’s multi-prong, “whole of government” approach to combatting the COVID-19 pandemic.

    The Complaint

    The nine-count complaint filed by the attorneys general representing each of the Plaintiff States alleges procedural and substantive violations that the government’s issuance of the IFR and the imposition of the CMS Mandate results in:

    1. substantive violation of the APA resulting in an arbitrary and capricious action not in accordance with law;
    2. substantive violation of the APA resulting in an action in excess of authority and not in accordance with law;
    3. procedural violations of the APA regarding notice and comment;
    4. procedural violations of the Social Security Act regarding notice and comment;
    5. violation of 42 U.S.C. § 1395z, which requires consultation with State agencies and other organizations in order to develop conditions of participation for providers of services;
    6. violation of 42 U.S.C. § 1302, which requires preparation of a regulatory impact analysis for rulemaking;
    7. unconstitutional exercise of federal spending powers by imposing a condition on the grant of federal funds;
    8. violation of the “Anti-Commandeering Doctrine,” which provides that Congress cannot directly compel state political branches to perform regulatory functions on the federal government’s behalf; and
    9. violations of the 10th Amendment of the U.S. Constitution and “federalism”.

    Requested Relief

    The Plaintiff States seek to have the CMS Mandate set aside, via preliminary and permanent injunction and to further preliminarily and permanently enjoin CMS from issuing a similar mandate without complying with notice and comment procedures under the APA and Social Security Act.

    Next Steps

    Given the short time until the December 6, 2021, Phase I compliance date identified in the IFR, health care providers and suppliers affected by the CMS Mandate should continue to prepare for implementation while watching for any actions in relation to this suit that may result in a delay of the anticipated compliance timeline.


    The Centers for Medicare and Medicaid Services (CMS) published an interim final rule with comment period (IFR) on November 5, 2021, that implements the Biden administration’s previously announced vaccine mandate for healthcare facilities. The expansive IFR applies to more than a dozen types of healthcare providers and suppliers (facilities), affects more than 10 million healthcare staff (defined broadly), and carries an anticipated potential price tag in excess of $1.3 billion dollars for the first year of implementation.

    In depth

    Overview

    The IFR focuses on facilities’ implementation of three key requirements, namely a process or plan to vaccinate all eligible staff, account for federally recognized exemptions from vaccination, and track and document staff vaccination. By December 6, 2021 (30 days after publication of the IFR), these processes and plans must be in place, and all eligible staff at covered Facilities must have received their first vaccine dose (for two-dose vaccines, or single dose of a one-dose vaccine) or have requested or been granted an exemption, and implemented the policies, procedures and recordkeeping controls required by the IFR. No later than January 4, 2022 (60 days after publication of the IFR), such staff must be “fully vaccinated”, obtained an exemption, or have a CDC-approved reason to temporarily delay vaccine administration. For purposes of the 60-day requirement, individuals that have received their second vaccine dose (or a single dose of a one-dose vaccine) will be considered compliant.

    • Federally recognized exemptions from vaccination (i.e., medical contraindications or religious beliefs) are permissible.
    • State-specific exemptions are not permissible. CMS states that its federal regulatory changes preempt contradictory state laws.
    • Prior infection with SARS-CoV2 and/or the presence of antibodies indicating prior infection with SARS-CoV2 (sometimes referred to as infection-conferred immunity), is not recognized as a basis for exemption from the vaccination requirement.
    • There is no “testing option” available as an alternative to vaccination.
    • Facilities must implement mitigations that accommodate staff who remain unvaccinated (i.e., staff that receive a federally recognized exemption) while reducing the risk of COVID-19 transmission.

    Facilities must also track and document evidence of staff vaccination in a manner that preserves the information’s privacy and security.

    Healthcare providers and suppliers must understand the answers to three key questions in order to assess the impact of the IFR on their operations and compliance:

    • What types of providers and suppliers are subject to compliance with the IFR?
    • What does the IFR require of facilities?
    • How will the IFR will be implemented and enforced?

    Providers and Suppliers Subject to the IFR

    CMS has broad authority to impose health and safety regulations as part of the Conditions of Participation, Conditions for Coverage or Requirements for Participation applicable to certain providers and suppliers enrolled in Medicare and/or Medicaid. Provider and supplier types that are subject to the IFR include the following:

    1. Ambulatory surgical centers
    2. Hospices
    3. Psychiatric residential treatment facilities
    4. Programs of All-Inclusive Care for the Elderly organizations
    5. Hospitals (acute care hospitals, psychiatric hospitals, hospital swing beds, long term care hospitals, children’s hospitals, transplant centers, cancer hospitals and rehabilitation hospitals/inpatient rehabilitation facilities)
    6. Long term care facilities, including skilled nursing facilities and nursing facilities
    7. Intermediate care facilities for individuals with intellectual disabilities
    8. Home health agencies
    9. Comprehensive outpatient rehabilitation facilities
    10. Critical access hospitals
    11. Clinics, rehabilitation agencies and public health agencies as providers of outpatient physical therapy and speech-language pathology services
    12. Community mental health centers
    13. Home infusion therapy suppliers
    14. Rural health clinics/federally qualified health centers
    15. End-stage renal disease facilities.

    Provider and Supplier Types Not Covered by the IFR

    Other types of providers or suppliers of healthcare services are not directly covered by the IFR, generally because they are not subject to CMS regulations that impose health and safety requirements. However, as noted below, there may be an indirect application to individual providers who provide services to a covered Facility.

    • Religious Nonmedical Healthcare Institutions. These providers do not provide medical items and services to patients, and any non-medical services provided to patients are not reimbursable by Medicare or Medicaid, placing them outside CMS regulatory authority.
    • Organ Procurement Organizations (OPOs). Because OPOs routinely provide services to hospitals without any in-person interaction with patients or staff, they are exempt from the requirement. However, if OPO personnel do interact in person with hospital patients and staff, the IFR vaccine requirement would apply to such individuals. Any additional contractual requirements imposed by hospitals on OPOs as contractors would be outside of the purview of the IFR.
    • Portable X-Ray Suppliers. Portable x-ray suppliers are not directly subject to the IFR. As with OPOs, however, if an arrangement with an entity subject to the IFR obligates that portable X-ray supplier personnel be vaccinated, then such requirement would be a matter of contract outside the purview of the IFR.
    • Physician Offices. Physician offices are not subject to CMS health and safety regulations. However, physicians and other licensed independent providers who have admitting or treating privileges at a hospital or other facility subject to the IFR will need to comply with the vaccination requirements in order for the facility to comply with the IFR.
    • Assisted Living Facilities, Group Homes and Similar Settings. Because CMS has no regulatory authority over these types of facilities, the IFR does not apply.

    Other components of the federal COVID-19 vaccine mandates may apply (i.e., the Occupational Safety and Health Administration’s COVID-19 vaccination and testing emergency temporary standard (OSHA ETS) or federal contractor requirements), see recent OTS here.

    Requirements for Covered Providers and Suppliers

    Who Are “Staff”?

    The IFR requires that covered facilities develop and implement policies and procedures under which all staff are vaccinated against COVID-19, including any individuals that perform their duties at any site of care or have the potential to contact anyone at the site of care (patients or other staff). “Staff” is defined broadly to include many categories of individuals, regardless of clinical responsibility, frequency of patient contact, whether services are provided in home or community settings, the duration of an individual’s tenure, or whether an individual has a contract or agreement with the covered facility. Specifically, the IFR identifies the following individuals as comprising “staff”:

    • Facility employees
    • Administrative staff
    • Facility leadership
    • Volunteer or other fiduciary board members
    • Housekeeping and food services
    • Licensed practitioners
    • Students and trainees
    • Volunteers
    • Individuals who provide care, treatment or other services for the facility and/or its patients under contract or other arrangement (including hospice and dialysis staff, physical therapists, occupational therapists, mental health professionals, social workers and portable x-ray suppliers).

    Limited exceptions to “staff” classification described in the IFR include:

    • Individuals performing 100% telework (i.e., individuals who do not come to the facility or interact with facility staff or patients)
    • “One-off” non-healthcare vendors, volunteers and professionals (e.g., annual elevator inspectors)
    • Individuals performing services exclusively off-site (e.g., accounting or auditing firms)
    • Individuals who infrequently enter a facility or site of care for limited, specific purposes and for a limited amount of time (e.g., delivery or repair personnel).

    Facilities are encouraged to extend the vaccination requirement beyond this list as they deem appropriate. Accordingly, a facility could elect to extend the vaccination requirement to the categories CMS has acknowledged as exceptions.

    Vaccination Requirement

    By December 6, 2021 (30 days after the IFR is published), all eligible staff at covered facilities must have received their first vaccine dose (for two-dose vaccines, or single dose of a one-dose vaccine) or requested an exemption, and implemented the policies, procedures and recordkeeping controls required by the IFR. No later than January 4, 2022 (60 days after publication of the IFR), such staff must be “fully vaccinated”, meaning for purposes of the IFR that they have received their second vaccine dose (or a single dose of a one-dose vaccine) obtained an exemption, or have a CDC-approved reason to temporarily delay vaccine administration. Federally recognized exemptions from vaccination (medical or religious exemptions) are permitted, but facilities are cautioned to evaluate exemption requests with care and within the boundaries of the federal requirements for exemptions. The IFR does not provide the option for facility staff to undergo COVID-19 testing in lieu of vaccination, and does not recognize infection-conferred immunity (i.e., evidence of past COVID-19 infection or the presence of antibodies to SARS-CoV-2) as an alternative to vaccination.

    Policies and Procedures

    By December 6, 2021 (30 days after the IFR is published), facilities must also have in place policies and procedures that address several infection control components, including:

    • A process to ensure that applicable staff are fully vaccinated in accordance with the IFR
    • Implementation of appropriate precautions to mitigate the spread of COVID-19 for any staff who are not required to be fully vaccinated
    • A plan for how the facility will track the vaccination status of staff, including any boosters or staff for whom vaccinations must be delayed
    • A plan for how the facility will track which staff are clinically contraindicated against obtaining a particular COVID-19 vaccine and a provider’s signed explanation for the contraindication
    • Contingency plans for staff who are not fully vaccinated.

    Enforcement of the IFR Requirements

    The requirements for facilities as set forth in the IFR will be subject to enforcement through the survey and certification process applicable to the facilities. State agencies (i.e., departments of health) acting as agents of CMS routinely survey facilities in response to complaints or during recertification surveys. Such surveys will now include compliance with vaccination policies and procedures, an assessment of COVID-19 cases over the preceding four weeks, and a list of staff vaccination status. Accrediting organizations such as The Joint Commission and the Accreditation Association for Ambulatory Health Care also will be required to include compliance with the requirements in their accreditation standards.

    Surveys that identify noncompliance will place the involved facility in a survey cycle that will require corrective action and, for some facility types, the threat of civil monetary penalties and denials of payment as already exist under applicable federal regulations. Timelines for coming into compliance will vary depending upon the severity of the noncompliance identified. The most significant “immediate jeopardy” findings that indicate serious noncompliance and significant risk to patients will result in a 23-day track for termination of the facility’s provider agreement. Other less severe findings (i.e., at a minor noncompliance “standard” or more substantial “condition” level) will provide a longer termination track and more time to come into compliance.

    CMS has stated that it views facility termination as a last resort and that it anticipates providing facilities with opportunities to come into compliance before termination.

    Policy Considerations

    CMS issued these requirements as an IFR rather than through its normal notice and comment rulemaking process, meaning that it came into effect without the need for further modification or changes. CMS primarily justifies this action based on the public health emergency and the agency’s use of IFRs to implement numerous other COVID-19 policies.

    Given that the IFR requirements impact many policy issues, specifically healthcare workforce shortages, and carry potentially significant enforcement penalties for certain providers, stakeholders are already questioning CMS’s process and the approach taken in the IFR. Some providers and suppliers have conveyed that CMS’ approach is dismissive of “real world” concerns, especially around staffing in an already-stressed staffing environment. In particular, stakeholders are concerned about the ways in which the broad scope and enforcement mechanisms, and the unknown impacts, may affect their operations.

    Broad Scope and Enforcement Mechanisms

    Initially, the Biden administration issued vaccine requirements only for nursing homes, finding that this care setting had a large number of COVID-19 infections and high mortality rates. The administration quickly pivoted to implementing vaccine mandates more broadly, however, with the new CMS rule applying to a wide range of Medicare and Medicaid certified healthcare facilities. Despite the significant shift, the IFR generally takes a one-size-fits-all approach and does not differentiate based on facility type, size or resources. This approach conflicts with most CMS policy, which normally tailors requirements to the site of care and provides exceptions or alternatives for small or rural entities.

    CMS acknowledges that it did not have to include termination of Medicare and Medicaid privileges, one of the strongest levers the agency could employ, as an enforcement mechanism. In the IFR, CMS outlines alternative approaches that it considered, such as reduced reimbursement rates, instead of threatening overall Medicare or Medicaid payment. Although CMS states that it does not intend to use this extreme measure in most cases and will allow for corrective action and time to remedy compliance, the agency is clearly sending a message that enforcement of the requirements will be taken seriously.

    Unknown Impacts

    Throughout the IFR, CMS assures facilities that the requirements should not impose significant additional burden. The agency points to the fact that it has already required reporting on vaccinations for healthcare providers in previous quality reporting measures and that it assumes that providers already have much of the policy infrastructure in place to track vaccination rates. The burden estimate, however, does not account for broader concerns that many stakeholders have about the mandate’s tie to healthcare workforce shortages, and the potential to worsen staff turnover rates.

    CMS pushes back against this concern, pointing out that the mandate should level vaccine requirements across most healthcare employers. Although CMS seems skeptical that the IFR will increase shortages, CMS recognizes that quantifying staffing impacts is challenging, and that its estimates may ultimately fail to capture the total number of lost staff and the overall effects the IFR could have on the healthcare workforce. The IFR also does not address how the mandate’s phases will interact with potential staffing and other challenges facing the healthcare industry.

    Key Takeaways

    Healthcare providers and suppliers should promptly determine if they are a covered facility under the IFR. If they are a covered facility, they must identify what personnel are “staff” that would be required to evidence or initiate vaccination or obtain a federally recognized exemption in advance of the 30-day deadline. If they are not a covered facility, they should determine if one of the other components of the federal vaccine mandate, such as the federal contractor mandate or the OSHA ETS, apply to them.

    Facilities covered by the IFR must also have implementing policies and procedures in place, and must establish mechanisms to document and track staff vaccination status. Such information must be tracked even for those staff exempt from vaccination (such as 100% telework staff).

    Individuals who are “staff” but who may not have previously been viewed as part of a facility vaccination plan (such as volunteers, trainees and board members) will require education and outreach to ensure compliance.

    Planning for enforcement activity by including the IFR components in survey readiness programs is advisable.

    Stakeholders are anticipated to provide comments during the comment period, and may also seek changes to the IFR to account for policy considerations.

    For more information or for assistance with this IFR, please contact one of the authors.

    Authors

    Sandra M. DiVarco

    Partner

    Chicago

    Kelsey R. Reinhardt

    Associate

    Los Angeles

    More insights

  • OFAC Reaffirms Focus on Virtual Currency with Updated Sanctions Law Guidance

    OFAC Reaffirms Focus on Virtual Currency with Updated Sanctions Law Guidance

    ARTICLE / CLIENT ALERT

    OFAC Reaffirms Focus on Virtual Currency with Updated Sanctions Law Guidance

    November 5, 2021

    Read time: 9 min

    Key takeaways
    Overview

    On October 15, 2021, the US Department of the Treasury’s Office of Foreign Asset Control (OFAC) announced updated guidance for virtual currency companies in meeting their obligations under US sanctions laws. On the same day, OFAC also issued guidance clarifying various cryptocurrency-related definitions.

    Coming on the heels of the Anti-Money Laundering Act of 2020—and in the context of the Biden administration’s effort to crackdown on ransomware attacks—the recent guidance is the latest indication that regulators are increasingly focusing on virtual currency and blockchain. In light of these developments, virtual currency market participants and service providers should ensure they are meeting their respective sanctions obligations by employing a “risk-based” anti-money laundering and sanctions compliance program.

    This update highlights the government’s continued movement toward subjecting the virtual currency industry to the same requirements, scrutiny and consequences in cases of noncompliance as applicable to traditional financial institutions.

    In depth

    The release of OFAC’s Sanctions Compliance Guidance for the Virtual Currency Industry indicates an increasing expectation for diligence as it has now made clear on several occasions that sanctions compliance “obligations are the same” for virtual currency companies who must employ an unspecified “risk-based” program (See: OFAC Consolidated Frequently asked Questions 560). OFAC published it with the stated goal of “help[ing] the virtual currency industry prevent exploitation by sanctioned persons and other illicit actors.”

    With this release, OFAC also provided some answers and updates to two of its published sets of “Frequently Asked Questions.”

    FAQ UPDATES (FAQ 559 AND 546)

    All are required to comply with the US sanctions compliance program, including persons and entities in the virtual currency and blockchain community. OFAC has said time and again that a “risk-based” program is required but that “there is no single compliance program or solution suitable for all circumstances” (See: FAQ 560). While market participants and service providers in the virtual currency industry must all comply, the risk of violating US sanctions are most acute for certain key service providers, such as cryptocurrency exchanges and over-the-counter (OTC) desks that facilitate large volumes of virtual currency transactions.

    OFAC previously used the term “digital currency” when it issued its first FAQ and guidance on the subject (FAQ 560), which stated that sanctions compliance is applicable to “digital currency” and that OFAC “may include as identifiers on the [Specially Designated Nationals and Blocked Persons] SDN List specific digital currency addresses associated with blocked persons.” Subsequently, OFAC placed certain digital currency addresses on the SDN List as identifiers.

    While OFAC previously used the term “digital currency,” in more recent FAQs and guidance, it has used a combination of the terms “digital currency” and “virtual currency” without defining those terms until it released FAQ 559.

    In FAQ 559, OFAC defines “virtual currency” as “a digital representation of value that functions as (i) a medium of exchange; (ii) a unit of account; and/or (iii) a store of value; and is neither issued nor granted by any jurisdiction.” This is a broad definition but likely encompasses most assets, which are commonly referred to as “cryptocurrency” or “tokens,” as most of these assets may be considered as “mediums of exchange.”

    OFAC also defines “digital currency” as “sovereign cryptocurrency, virtual currency (non-fiat), and a digital representation of fiat currency.” This definition appears to be an obvious effort by OFAC to make clear that its definitions include virtual currencies issued or backed by foreign governments and stablecoins.

    The reference to “sovereign cryptocurrency” is focused on cryptocurrency issued by foreign governments, such as Venezuela. This is not the first time OFAC has focused on sovereign cryptocurrency. It ascribed the use of sovereign backed cryptocurrencies as a high-risk vector for US sanctions circumvention. Executive Order (EO) 13827, which was issued on March 19, 2018, explicitly stated:

    In light of recent actions taken by the Maduro regime to attempt to circumvent U.S. sanctions by issuing a digital currency in a process that Venezuela’s democratically elected National Assembly has denounced as unlawful, hereby order as follows: Section 1. (a) All transactions related to, provision of financing for, and other dealings in, by a United States person or within the United States, and digital currency, digital coin, or digital token, that was issued by, for, or on behalf of the Government of Venezuela on or after January 9, 2018, are prohibited as of the effective date of this order.

    On March 19, 2018, OFAC issued FAQs 564, 565 and 566, which were specifically focused on Venezuela issued cryptocurrencies, stating that “petro” and “petro gold” are considered a “digital currency, digital coin, or digital token” subject to EO 13827. While OFAC has not issued specific FAQs or guidance on other sovereign backed cryptocurrencies, it may be concerned that a series of countries have stated publicly that they plan to test and launch sovereign backed securities, including Russia, Iran, China, Japan, England, Sweden, Australia, the Netherlands, Singapore and India. With the release if its most recent FAQs, OFAC is reaffirming that it views sovereign cryptocurrencies as highly risky and well within the scope of US sanctions programs.

    The reference to a “digital representation of fiat currency” appears to be a reference to “stablecoins.” In theory, stablecoins are each worth a specified value in fiat currency (usually one USD each). Most stablecoins were touted as being completely backed by fiat currency stored in segregated bank accounts. The viability and safety of stablecoins, however, has recently been called into question. One of the biggest players in the stablecoin industry is Tether, who was recently fined $41 million by the US Commodities Futures Trading Commission for failing to have the appropriate fiat reserves backing its highly popular stablecoin US Dollar Token (USDT). OFAC appears to have taken notice and states in its FAQ that “digital representations of fiat currency” are covered by its regulations and FAQs.

    FAQ 646 provides some guidance on how cryptocurrency exchanges and other service providers should implement a “block” on virtual currency. Any US persons (or persons subject to US jurisdiction), including financial institutions, are required under US sanctions programs to “block” assets, which requires freezing assets and notifying OFAC within 10 days. (See: 31 C.F.R. § 501.603 (b)(1)(i).) FAQ 646 makes clear that “blocking” obligations applies to virtual currency and also indicates that OFAC expects cryptocurrency exchanges and other service providers be required to “block” the virtual currency at issue and freeze all other virtual currency wallets “in which a blocked person has an interest.”

    Depending on the strength of the anti-money laundering/know-your-customer (AML/KYC) policies employed, it will likely prove difficult for cryptocurrency exchanges and other service providers to be sure that they have identified all associated virtual currency wallets in which a “blocked person has an interest.” It is possible that a cryptocurrency exchange could onboard a customer who complied with an appropriate risk-based AML/KYC policy and, unbeknownst to the cryptocurrency exchange, a blocked person “has an interest” in one of the virtual currency wallets. It remains to be seen how OFAC will employ this “has an interest” standard and whether it will take any cryptocurrency exchanges or other service providers to task for not blocking virtual currency wallets in which a blocked person “has an interest.” It is important for cryptocurrency exchanges or other service providers to implement an appropriate risk-based AML/KYC policy to defend any inquiries from OFAC as to whether it has complied with the various US sanctions programs, including by having the ability to identify other virtual currency wallets in which a blocked person “has an interest.”

    UPDATED SANCTIONS COMPLIANCE GUIDANCE

    OFAC’s recent framework for OFAC Compliance Commitments outlines five essential components for a virtual currency operator’s sanctions compliance program. These components generally track those applicable to more traditional financial institutions and include:

    1. Senior management should ensure that adequate resources are devoted to the support of compliance, that a competent sanctions compliance officer is appointed and that adequate independence is granted to the compliance unit to carry out their role.
    2. An operative risk assessment should be fashioned to reflect the unique exposure of the company. OFAC maintains both a public use sanctions list and a free search tool for that list which should be employed to identify and prevent sanctioned individuals and entities from accessing the company’s services.
    3. Internal controls must be put in place that address the unique risks recognized by the company’s risk assessment. OFAC does not have a specific software or hardware requirement regarding internal controls.
      1. Although OFAC does not specify required internal controls, it does provide recommended best practices. These include geolocation tools with IP address blocking controls, KYC procedures for both individuals and entities, transaction monitoring and investigation software that can review historically identified bad actors, the implementation of remedial measures upon internal discovery of weakness in sanction compliance, sanction screening and establishing risk indicators or red flags that require additional scrutiny when triggered.
      2. Additionally, information should be obtained upon the formation of each new customer relationship. A formal due diligence plan should be in place and operated sufficiently to alert the service provider to possible sanctions-related alarms. Customer data should be maintained and updated through the lifecycle of that customer relationship.
    4. To ensure an entity’s sanctions compliance program is effective and efficient, that entity should regularly test their compliance against independent objective testing and auditing functions.
    5. Proper training must be provided to a company’s workforce. For a company’s sanctions compliance program to be effective, its workforce must be properly outfitted with the hard and soft skills required to execute its compliance program. Although training programs may vary, OFAC training should be provided annually for all employees.

    KEY TAKEAWAYS

    As noted in OFAC’s press release issued simultaneously with the updated FAQ’s, “[t]hese actions are a part of the Biden Administration’s focused, integrated effort to counter the ransomware threat.” The Biden administration’s increased focus on regulatory and enforcement action in the virtual currency space highlights the importance for market participants and service providers to implement a robust compliance program. Cryptocurrency exchanges and other service providers must take special care in drafting and implementing their respective AML/KYC policies and in ensuring the existence of risk-based AML and sanctions compliance programs, which includes a periodic training program. When responding to inquiries from OFAC or other regulators, it will be critical to have documented evidence of the implementation of a risk-based AML/KYC program and proof that employees have been appropriately trained on all applicable policies, including a sanctions compliance policy.

    Ethan Heller, a law clerk in our New York office, also contributed to this article.

    Authors

    Joseph B. Evans

    Partner

    New York – One Vanderbilt Avenue

    Edward B. Diskant

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • IRS Announces 2022 Employee Benefit Plan Limits

    IRS Announces 2022 Employee Benefit Plan Limits

    ARTICLE / CLIENT ALERT

    IRS Announces 2022 Employee Benefit Plan Limits

    November 10, 2021

    Read time: 3 min

    Key takeaways
    Overview

    The Internal Revenue Service (IRS) recently announced the cost-of-living adjustments to the applicable dollar limits for various employer-sponsored retirement and welfare plans for 2022. Most of the dollar limits currently in effect for 2021 will increase.

    In depth

    The IRS and the Social Security Administration announced the cost-of-living adjustments to the applicable dollar limits on various employer-sponsored retirement and welfare plans and the Social Security wage base for 2022. The table below compares the applicable dollar limits for certain employee benefit programs and the Social Security wage base for 2021 and 2022.*

    RETIREMENT PLAN LIMITS (guidance link) 2021 Δ 2022
    Annual compensation limit $290,000 ↑ $305,000
    401(k), 403(b) & 457(b) before-tax contributions $19,500 ↑ $20,500
    Catch-up contributions (if age 50 or older) $6,500 ═ $6,500
    Highly compensated employee threshold $130,000 ↑ $135,000
    Key employee officer compensation threshold $185,000 ↑ $200,000
    Defined benefit plan annual benefit and accrual limit $230,000 ↑ $245,000
    Defined contribution plan annual contribution limit $58,000 ↑ $61,000
    Employee stock ownership plan (ESOP) limit for determining the lengthening of the general five-year distribution period $230,000 ↑ $245,000
    ESOP limit for determining the maximum account balance subject to the general five-year distribution period $1,165,000 ↑ $1,230,000
    HEALTH AND WELFARE PLAN LIMITS (guidance links here and here) 2021 Δ 2022
    Health Flexible Spending Accounts
    Maximum salary reduction limit $2,750 ↑ $2,850
    Health FSA Carryover Limit $550 ↑ $570
    Dependent Care Flexible Spending Accounts±
    If employee is married and filing a joint return or if the employee is a single parent $10,500 ↓ $5,000
    In employee is married but filing separately $5,250 ↓ $2,500
    Excepted Benefit Health Reimbursement Arrangements $1,800 ═ $1,800 
    Qualified Transportation Fringe Benefit and Qualified Parking (monthly limit) $270 ↑ $280
    High Deductible Health Plans (HDHP) and Health Savings Accounts (HSA)
    HDHP – Maximum annual out-of-pocket limit (excluding premiums):
    Self-only coverage $7,000 ↑ $7,050
    Family coverage $14,000 ↑ $14,100
    HDHP – Minimum annual deductible:
    Self-only coverage $1,400 ═ $1,400
    Family coverage $2,800 ═ $2,800
    HSA – Annual contribution limit:
    Self-only coverage $3,600 ↑ $3,650
    Family coverage $7,200 ↑ $7,300
    Catch-up contributions (age 55 or older)± $1,000 ═ $1,000
    SOCIAL SECURITY WAGE BASE (guidance link) 2021 Δ 2022
    Social Security Maximum Taxable Earnings $142,800 ↑ $147,000

    Plan sponsors should update payroll and plan administration systems for the 2022 cost-of-living adjustments and should incorporate the new limits in relevant participant communications, like open enrollment materials and summary plan descriptions.

    For further information about applying the new employee benefit plan limits for 2022, contact your regular McDermott lawyer.


    * The dollar limits are generally applied on a calendar year basis; however, certain dollar limits are applied on a plan-year, tax-year or limitation-year basis.

    ± Not indexed for cost-of-living adjustments, with the exception of limited guidance issued for 2021.

     

    Authors

    Jacob M. Mattinson

    Partner

    Chicago

    Brian J. Tiemann

    Partner

    Chicago

    More insights

  • Personal Liability of the Supervisory Board in a Corporate Crisis

    ARTICLE

    Personal Liability of the Supervisory Board in a Corporate Crisis

    November 2021

    Read time: 10 min

    Key takeaways
    Overview

    In their article, Renate Prinz and Katharina Gerdes, lawyer/partner in the area of restructuring and reorganization at the law firm BRL BOEGE ROHDE LUEBBEHUESEN, discuss the do’s and don’ts of avoiding personal liability.

    In depth
    Authors
    More insights

  • Trends in Data Privacy Litigation | Q4 2021

    Trends in Data Privacy Litigation | Q4 2021

    ARTICLE / CLIENT ALERT / VIDEO

    Trends in Data Privacy Litigation | Q4 2021

    November 4, 2021

    Read time: 3 min

    Overview

    With the increased attention to and explosion of laws related to consumer privacy and cybersecurity, companies must defend their privacy practices in court and regulatory arenas now more than ever before.

    McDermott’s Global Privacy & Cybersecurity Practice Group is closely monitoring developments across an array of privacy-related litigations and regulatory matters. We position ourselves at the vantage point to see around the corner for clients. Whether it be awaiting the potentially seismic rulings related to the Biometric Information Privacy Act (BIPA), analyzing how the government’s narrowed enforcement lens on Big Tech may impact businesses or reading the tea leaves around the next wave of privacy legislation, the McDermott team is positioned to proactively protect our clients—and defend them, when necessary.

    We will be providing a quarterly update regarding key privacy litigation watch outs for businesses. To contact us about anything in these updates or for your litigation needs, please contact David Saunders.

    In depth
    Conclusion

    David P. Saunders

    Partner

    Chicago

    More insights

  • OSHA and CMS Vaccination Rules Released: Here Are the Details

    OSHA and CMS Vaccination Rules Released: Here Are the Details

    ARTICLE / CLIENT ALERT

    OSHA and CMS Vaccination Rules Released: Here Are the Details

    November 4, 2021

    Read time: 9 min

    Key takeaways
    Overview

    UPDATE (12/29/2021):

    See update on CMS enforcement.


    UPDATE (12/22/2021):

    As of December 15, 2021, the CMS IFR has been reinstated in 25 states. As of December 17, 2021, the OSHA “vax or test” ETS has been reinstated nationwide, with enforcement dates beginning in January 2022. The federal contractor mandate remains under a nationwide stay, with no enforcement currently permitted. Read more here.


    On November 4, 2021, the US Occupational Safety and Health Administration (OSHA) unveiled its Emergency Temporary Standard (ETS) to protect employees of large employers in all industries from COVID-19. The Centers for Medicare and Medicaid Services (CMS) simultaneously released its Omnibus COVID-19 Health Care Staff Vaccination Interim Final Rule, applicable to most Medicare- and Medicaid-certified providers and suppliers, which must be met to continue participation in Medicare and Medicaid programs. Finally, the White House announced that its previously published federal contractor vaccination mandate would be updated to move the compliance deadline from December 8, 2021, to January 4, 2022.

    In depth

    OSHA ETS

    Key highlights of OSHA’s ETS include the following:

    • Vax-or-Test: By January 4, 2022, all employees of large employers (i.e., those with at least 100 employees) must be fully vaccinated or show a weekly negative COVID-19 test.
    • Paid Time Off: Beginning December 5, 2021, large employers must provide paid time off for employees to receive the vaccine and recover from any side effects caused by the vaccine. Specifically, the ETS requires all covered employers to support vaccination by providing employees with “reasonable” time—including up to four hours of paid time—to receive each primary vaccination dose, and “reasonable” time and paid sick leave to recover from primary vaccination dose side effects.
    • Paying for Tests: Generally speaking, OSHA’s position is that large employers are not required to provide, or pay for, COVID-19 tests if their employees choose not to be vaccinated; however, employers will still need to pay for the tests if employees are unable to be vaccinated due to legally protected reasons (i.e., disability or sincerely held religious belief). (Note that other federal and state laws may still require certain reimbursements or compensation for time beyond what the OSHA ETS provides.)
    • Masks for Unvaccinated Employees: If an employee is not vaccinated, the employer must ensure the employee wears a face mask while in the workplace.
    • Exempted Employees: Employees who work completely remotely or who work only outdoors are included for purposes of the 100-employee count, but they are exempt from the “vax-or-test” requirements. That said, employees who work primarily remotely but who do some work where other people are present (e.g., an office) are covered and must be vaccinated or test; however, the frequency of testing in that situation would depend on how often they perform work where others are present.

    The OSHA regulation is also clear about how it interacts with other standards already in place:

    • Interaction with Stricter Employer Policies: Employers may impose stricter vaccine mandates that do not include a testing option, subject to legally protected reasons for remaining unvaccinated.
    • Interaction with State OSHA Plans: In the 22 states that maintain their own state OSHA (e.g., Cal/OSHA), the state OSHA will be responsible for either adopting the federal OSHA ETS as written or modifying it to impose stricter requirements. Likewise, this ETS does not replace existing state or local vaccination requirements, such as requirements that all indoor dining patrons be fully vaccinated.
    • Interaction with OSHA’s Healthcare ETS: Employers and workplaces who are covered by OSHA’s ETS for the healthcare industry remain bound by those requirements.
    • Interaction with the CMS Rule (described below): The OSHA rule will not apply to workplaces that receive Medicare or Medicaid funds, as these workplaces are covered by the CMS rule described in further detail below.

    CMS INTERIM FINAL RULE

    The CMS interim final rule (IFR) applies to certain facilities that receive payment under Medicare and/or Medicaid.

    • Deadline for Compliance: The IFR provides that covered facilities must ensure that all eligible staff have received the first dose of a two-dose COVID-19 vaccine or a one-dose COVID-19 vaccine prior to providing any care, treatment or other services by December 5, 2021. All eligible staff must have received the necessary shots to be fully vaccinated—either two doses of Pfizer or Moderna or one dose of Johnson & Johnson—by January 4, 2022.
    • Eligible staff includes: facility employees; licensed practitioners; students, trainees, and volunteers; and individuals who provide care, treatment, or other services for the facility and/or its patients, under contract or other arrangement. In addition, contractors and others with direct or indirect patient contact—including administrative staff, facility leadership, volunteer or other fiduciary board members and environmental services staff—are covered by the rule. Very limited exceptions apply.
    • Facilities covered by the regulation include:
      • Ambulatory Surgical Centers, Hospices, Programs of All-Inclusive Care for the Elderly (PACE), Hospitals (all types), Long Term Care Facilities (including SNFs), Psychiatric Residential Treatment Facilities, Intermediate Care Facilities for Individuals with Intellectual Disabilities, Home Health Agencies, Comprehensive Outpatient Rehabilitation Facilities, Critical Access Hospitals, Clinics, Community Mental Health Centers, Home Infusion Therapy Suppliers, Rural Health Clinics/Federally Qualified Health Centers and End-Stage Renal Disease Facilities
      • Note: The CMS rule does not directly apply to other health care entities, such as physician offices, that are not regulated by CMS; however, other components of the IFR (and/or other federal mandates, such as the OSHA ETS and federal contractor rules) may apply to these entities.
    • Exemptions to vaccination requirement: The rule provides for exemptions based on recognized medical conditions or religious beliefs, observances or practices. Facilities must develop a similar process or policy for permitting exemptions that aligns with federal law.
    • No Testing Option: The IFR does not include testing as an alternative to vaccination (i.e., “Vax or Test” is not permitted, unlike the OSHA ETS).
    • Enforcement: CMS will ensure compliance through established survey and enforcement processes. If a provider or supplier does not meet the requirements, it will first be cited as being noncompliant and will have an opportunity to comply before CMS takes additional action, which could include termination of the facility’s Medicare/Medicaid provider agreement.
    • The rule will be implemented in two phases:
      • In Phase 1 (within 30 days after rule publication), eligible staff must have received their first dose or a documented exemption.
      • In Phase 2, (within 60 days of rule publication), eligible employees must have received their second dose.

    FEDERAL CONTRACTOR VACCINATION MANDATE

    The White House announced that its previously published federal contractor vaccination mandate would be updated to move the initial vaccination compliance deadline from December 8, 2021, to January 4, 2022. Further details of the federal contractor mandate are available in McDermott’s previously published client alert, “Federal contractor COVID-19 vaccine mandate clock is ticking.”


    UPDATE (11/17/2021):

    On November 16, 2021, 12 additional states filed a complaint in the US District Court for the Western District of Louisiana requesting that the Interim Final Rule with comment period (IFR) that put in place the vaccination mandate applicable to certain covered health care facilities and staff (the CMS Mandate) be set aside as an “unlawful agency action under the Administrative Procedure Act” (APA), 5 U.S.C. §§ 701–706. This challenge follows similar actions by 10 attorneys general against the CMS Mandate on November 10, 2021, in the US District Court for the Eastern District of Missouri and against the Occupational Safety and Health Administration’s (OSHA) Emergency Temporary Standard (OSHA ETS), which mandates vaccination or testing for employees of companies with 100+ employees. The OSHA ETS was stayed by the US Court of Appeals for the Fifth Circuit on November 12, 2021, and has been consolidated with other challenges before the US Court of Appeals for the Sixth Circuit for reconsideration. Both the IFR and the OSHA ETS were released on November 5, 2021, as part of the Biden administration’s multi-prong “whole of government” approach to combatting the COVID-19 pandemic. Given the short time until the December 6, 2021, first compliance deadline for the IFR and ETS, employers affected by these rules should continue to prepare for implementation while watching for any actions in relation to this suit that may result in a delay of the anticipated compliance timeline.


    UPDATE (11/11/2021):

    On November 10, 2021, 10 states filed a complaint in the US District Court for the Eastern District of Missouri requesting that the Centers for Medicare and Medicaid Services (CMS) Interim Final Rule with comment period (IFR) that put in place the vaccination mandate applicable to certain covered healthcare facilities and staff (the CMS Mandate) be set aside as an “unlawful agency action under the Administrative Procedure Act” (APA), 5 U.S.C. §§ 701–706. The plaintiff states seek to have the CMS Mandate set aside, via preliminary and permanent injunction, and to further preliminarily and permanently enjoin CMS from issuing a similar mandate without complying with notice and comment procedures under the APA and Social Security Act.


    UPDATE (11/11/2021):

    On November 10, 2021, the Safer Federal Workforce Task Force updated its guidance for federal contractors to move the December 8, 2021, deadline to January 18, 2022. This means that covered contractor employees must receive their final vaccination shot by January 4, 2022, in order to be fully vaccinated by the January 18 deadline. 


    UPDATE (11/07/2021):

    On November 6, 2021, the US Court of Appeals for the Fifth Circuit in Louisiana temporarily blocked the Emergency Temporary Standard (ETS) issued on November 4, 2021, by the Occupational Safety and Health Administration (OSHA) requiring employers with 100 or more employees to implement COVID-19 vaccination policies. The Fifth Circuit wrote that the pending lawsuit raised “cause to believe that there are grave statutory and constitutional issues” surrounding the ETS. The ETS is stayed until further notice, halting its implementation temporarily. The Court ordered the parties to submit further briefing on the validity of the ETS by November 8 and 9. While the future of the ETS remains uncertain, planning for employers to comply with the current ETS deadlines will take additional time, and employers may want to continue preparing for the ETS as if it is going to take effect while litigation continues. 

    Authors

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    Sandra M. DiVarco

    Partner

    Chicago

    More insights